1360 Treatment with a novel hexavalent OX40 agonist remodels the tumor microenvironment to favor anti-tumor immunity in mice - William L Redmond; Melissa Kasiewicz; Annah Rolig; Yaiza Diaz De Durana; Rashi Yadav (Journal for ImmunoTherapy of Cancer, 2023)